Jeil Pharmaceutical Co., Ltd.
Jeil Pharmaceutical Co., Ltd.
Explore linked clinical trials.3 results · Page 1 of 1
Clinical trials
Swipe the table sideways for more columns.
| Trial | Conditions | Status | Phase | Updated | More info | NCT ID |
|---|---|---|---|---|---|---|
| Zastaprazan for the prEvention of Upper GI Bleeding in Ischemic Stroke | brain disorder, brain ischemia, cardiovascular disorder, central nervous system disorder, cerebrovascular disorder, ischemic stroke, nervous system disorder, stroke disorder, transient ischemic attack, vascular disorder | Not yet recruiting | Phase 3 | 2026-10-09 | NCT07730840 | |
| Effect of ZaStaprazan on Platelet Reactivity of Clopidogrel After PercuTaneous CoronAry InteRvention | Chronic Coronary Syndrome | Recruiting | Phase 4 | 2026-04-24 | NCT07471867 | |
| JAQBO® Tab. 20 mg(Zastaprazan Citrate) in Erosive GERD | Erosive Gastroesophageal Reflux Disease | Not yet recruiting | Not stated | 2025-08-14 | NCT07115706 |